Exclusive

Publication

Byline

Location

US Patent Issued to KYMAB on Aug. 11 for "Treatment of atopic dermatitis" (French, British Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,754, issued on Aug. 11, was assigned to KYMAB Ltd. (Cambridge, Great Britain). "Treatment of atopic dermatitis" was invented by Ben Porter-... Read More


US Patent Issued to HARBOUR BIOMED (SUZHOU) on Aug. 11 for "Antibody targeting BCMA, bispecific antibody, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,755, issued on Aug. 11, was assigned to HARBOUR BIOMED (SUZHOU) Co. LTD. (Suzhou, China). "Antibody targeting BCMA, bispecific antibody, an... Read More


US Patent Issued to CUROCELL, EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION on Aug. 11 for "BCMA-specific antibody and chimeric antigen receptor" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,756, issued on Aug. 11, was assigned to CUROCELL INC. (Daejeon, South Korea) and EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (Seoul, S... Read More


US Patent Issued to City of Hope on Aug. 11 for "Anti-HVEM antibodies" (American, Taiwanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,757, issued on Aug. 11, was assigned to City of Hope (Duarte, Calif.). "Anti-HVEM antibodies" was invented by Flavia Pichiorri (La Canada, ... Read More


US Patent Issued to CHANGQING GENRIX BIOPHARMACEUTICAL on Aug. 11 for "Anti-CD3E/BCMA bispecific antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,758, issued on Aug. 11, was assigned to CHANGQING GENRIX BIOPHARMACEUTICAL Co. LTD. (Chongqing, China). "Anti-CD3E/BCMA bispecific antibody... Read More


US Patent Issued to Legend Biotech USA on Aug. 11 for "CD19 binding molecules and uses thereof" (Chinese, Canadian Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,759, issued on Aug. 11, was assigned to Legend Biotech USA Inc. (Somerset, N.J.). "CD19 binding molecules and uses thereof" was invented by... Read More


US Patent Issued to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION on Aug. 11 for "Molecules that bind to CD66e polypeptides" (Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,760, issued on Aug. 11, was assigned to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh). "Molecules th... Read More


US Patent Issued to Denali Therapeutics on Aug. 11 for "Anti-HER2 antibodies and methods of use thereof" (California, New York Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,761, issued on Aug. 11, was assigned to Denali Therapeutics Inc. (South San Francisco, Calif.). "Anti-HER2 antibodies and methods of use th... Read More


US Patent Issued to Novartis on Aug. 11 for "Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof" (Swiss, American Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,762, issued on Aug. 11, was assigned to Novartis AG (Basel, Switzerland). "Reversal binding agents for anti-factor XI/XIa antibodies and us... Read More


US Patent Issued to BIOSION on Aug. 11 for "Antibodies binding C5 and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,763, issued on Aug. 11, was assigned to BIOSION INC. (Nanjing, China). "Antibodies binding C5 and uses thereof" was invented by Mingjiu Che... Read More